SerbinCreative

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbincreative.com LA / NY / UK

DNA Illustrations, Inc.

Inhibition of PI3K Pathway 

Prev Next
Previous

IV Treatment

medical illustration of Mechanism of action of Duvelisib (Copiktra); oral delta and gamma PI3K inhibitor. This dual isoform blockage inhibits cell signaling within malignant B cells and between malignant cells and the tumor microenvironment (TME). Blocking PI3K delta pathways from activated BCR, cytokine, and CD40 receptors affects the growth and survival of malignant B cells.
Next medical illustration of Deleterious mutations in the BCRA1 and BCRA2 genes are the most common cause of hereditary breast and ovarian cancer. Illustration shows dramatization of extraction of DNA from a blood test. Chromosomes 17 and 13 show the location of BCRA mutations leading to double DNA breaks.

BCRA1 BCRA2 Genetic Testing

Mechanism of action of Duvelisib (Copiktra); oral delta and gamma PI3K inhibitor. This dual isoform blockage inhibits cell signaling within malignant B cells and between malignant cells and the tumor microenvironment (TME). Blocking PI3K delta pathways from activated BCR, cytokine, and CD40 receptors affects the growth and survival of malignant B cells.

Keywords: Color, Editorial, Cell biology / Histology, Oncology, Mechanism of Action (MOA)

© DNA Illustrations